Vernal Biosciences
PrivateLast Round
Series A
Extension
Jun 15, 2023
Total Funding Raised
$20M
Company Overview
Vernal Biosciences operates in Healthcare & Life Sciences and is based in Colchester, Vermont. Its latest recorded funding round was a Series A Extension round in June 2023.
Vernal Biosciences is a biotechnology company that provides high-purity mRNA and LNP-mRNA manufacturing services for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vernal Biosciences Comparables
Compare Vernal Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RiboPro | 90% | |
| Helix Biotech | 87% | |
| ARCALIS, Inc. | 83% |
For institutional investors. Book with your work email.
Vernal Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 15, 2023 | ||||
| VC Round | Jun 2, 2022 | ||||
| Seed | Jul 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vernal Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dynamk Capital | Series A Extension, VC Round |
| Ampersand Capital | VC Round, Series A Extension |
| Vermont Center for Emerging Technologies | Seed, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2023
$20M round led by Ampersand Capital and Charles River Laboratories
- Jun 2, 2022
$21M round led by Ampersand Capital and Dynamk Capital.
For institutional investors. Book with your work email.
Vernal Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vernal Biosciences's valuation, stock price, and market status.
Is Vernal Biosciences a public or private company?
Vernal Biosciences is a private company.
What is the current stock price of Vernal Biosciences?
Vernal Biosciences is a private company, so its shares have no public market price. Caplight tracks Vernal Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vernal Biosciences worth (valuation)?
Valuation information for Vernal Biosciences is not publicly available.
Can I buy Vernal Biosciences stock?
Vernal Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vernal Biosciences's last funding round?
Vernal Biosciences's most recent funding round was Series A Extension on June 15, 2023.
Who are the main investors in Vernal Biosciences?
Key investors in Vernal Biosciences include Dynamk Capital, Ampersand Capital.
Will Vernal Biosciences IPO soon?
No public IPO plans have been announced for Vernal Biosciences.
How can I track Vernal Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Vernal Biosciences's shares on secondary markets.